Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Patients × Omeprazole × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Prostate Cancer Patients 1 Pharmacokinetics of MDV3100 1 Neoplasms 1

Interventions

repaglinide 1 carbon-11 acetate 1 Warfarin 1 Omeprazole 1 Midazolam 1 Interviews as Topic 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04676035 2023-02-09

The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed

Prostate Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡